[{"NetIncomeLoss_1_Q2_USD":-22122000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_0_Q2_USD":3.92,"GeneralAndAdministrativeExpense_2_Q2_USD":11539000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":7764000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":48449.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":49199.0,"AccruedLiabilitiesCurrent_0_Q2_USD":4151000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":98000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_0_Q2_USD":45648000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":19951000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":103270000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.23,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_2_Q2_shares":1189000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":380000.0,"AvailableForSaleSecurities_0_Q2_USD":26268000.0,"CurrentStateAndLocalTaxExpenseBenefit_2_Q2_USD":500000.0,"CommonStockSharesIssued_0_Q2_shares":56215596.0,"Assets_0_Q2_USD":175755000.0,"OtherComprehensiveIncomeLossNetOfTax_2_Q2_USD":98000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q2_USD":-112000.0,"ShareBasedCompensation_2_Q2_USD":2513000.0,"ShareBasedCompensation_1_Q2_USD":1277000.0,"MarketableSecuritiesCurrent_0_Q2_USD":26268000.0,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q2_USD":26170000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":98000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":15032000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_0_Q2_USD":7.54,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":2086000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_2_Q2_pure":0.73,"IncomeTaxExpenseBenefit_2_Q2_USD":-523000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":-523000.0,"CommonStockValue_0_Q2_USD":6000.0,"ProceedsFromIssuanceOrSaleOfEquity_2_Q2_USD":103270000.0,"AvailableForSaleSecuritiesAndHeldToMaturitySecurities_0_Q2_USD":26300000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAociForInvestmentTransferredFromAvailableForSaleToEquityMethodAfterTax_2_Q2_USD":null,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAociForInvestmentTransferredFromAvailableForSaleToEquityMethodAfterTax_1_Q2_USD":null,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":null,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":113713000.0,"StockIssuedDuringPeriodValueOther_1_Q2_USD":9869000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_2_Q2_USD":29000000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-34606000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-22234000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":6053000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_2_Q2_pure":0.0105,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":145887000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-112000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_2_Q2_shares":124000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_2_Q2_USD":98000.0,"OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax_1_Q2_USD":-112000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q2_shares":2482000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-113765000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":106722000.0,"CommonStockSharesOutstanding_0_Q2_shares":56215596.0,"PaymentsToAcquireMarketableSecurities_2_Q2_USD":9049000.0,"IncreaseDecreaseInAccruedInterestReceivableNet_2_Q2_USD":-43000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-35227000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-22645000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-26942000.0,"LiabilitiesCurrent_0_Q2_USD":11979000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q2_shares":6846000.0,"AccountsPayableCurrent_0_Q2_USD":7828000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":574000.0,"ProceedsFromStockOptionsExercised_1_Q2_USD":380000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":62000.0,"AdditionalPaidInCapital_0_Q2_USD":277437000.0,"AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue_0_Q2_USD":0.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":145887000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_2_Q2_shares":113000.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_0_Q2_USD":25304000.0,"NetIncomeLoss_2_Q2_USD":-34704000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":3600000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":24122000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":-44000.0,"ProfitLoss_1_Q2_USD":-22122000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":2977000.0,"CommonStockSharesAuthorized_0_Q2_shares":100000000.0,"OperatingIncomeLoss_2_Q2_USD":-35661000.0,"OperatingIncomeLoss_1_Q2_USD":-22796000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_2_Q2_USD":953000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_1_Q2_USD":323000.0,"InvestmentIncomeInterest_2_Q2_USD":434000.0,"InvestmentIncomeInterest_1_Q2_USD":151000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_2_Q2_pure":null,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":98000.0,"StockholdersEquity_0_Q2_USD":163776000.0,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_2_Q2_USD":13.09,"ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_2_Q2_USD":5.12,"LiabilitiesAndStockholdersEquity_0_Q2_USD":175755000.0,"PreferredStockSharesAuthorized_0_Q2_shares":25000000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_2_Q2_shares":157065.0,"SharePrice_0_Q2_USD":13.09,"OperatingExpenses_2_Q2_USD":35661000.0,"OperatingExpenses_1_Q2_USD":22796000.0,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-0.45,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-0.72,"ProfitLoss_2_Q2_USD":-34704000.0,"PreferredStockValue_0_Q2_USD":null,"AccruedProfessionalFeesCurrent_0_Q2_USD":514000.0,"Ticker":"PRVB","CIK":"1695357","name":"PROVENTION BIO, INC.","OfficialName":"Provention Bio Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"371519921.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200806"}]